Michael Shipley

2.9k total citations · 1 hit paper
24 papers, 2.3k citations indexed

About

Michael Shipley is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Michael Shipley has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 8 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Michael Shipley's work include Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Michael Shipley is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Michael Shipley collaborates with scholars based in United Kingdom, United States and Australia. Michael Shipley's co-authors include M. J. H. Smith, M.A. Bray, A. W. Ford‐Hutchinson, Mira Doig, Alan J. Silman, M Corbett, Amanda Young, Seamus E. Dalton, A. B. Kurtz and Fiona Cunningham and has published in prestigious journals such as Nature, The Lancet and Spine.

In The Last Decade

Michael Shipley

23 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

1980 1.7k citations M.A. Bray, Mira Doig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Shipley United Kingdom	14	723	645	493	409	295	24	2.3k
J Björk Sweden	16	492 0.7×	450 0.7×	245 0.5×	340 0.8×	105 0.4×	22	1.7k
M. M. Monick United States	20	742 1.0×	535 0.8×	277 0.6×	398 1.0×	110 0.4×	27	2.0k
Haruhisa Mita Japan	30	1.3k 1.8×	495 0.8×	489 1.0×	314 0.8×	331 1.1×	103	2.5k
Adrian Moore United Kingdom	29	317 0.4×	559 0.9×	520 1.1×	1.6k 4.0×	389 1.3×	78	3.2k
Marc E. Goldyne United States	24	546 0.8×	421 0.7×	1.0k 2.1×	740 1.8×	86 0.3×	45	2.7k
E. S. K. Assem United Kingdom	22	567 0.8×	421 0.7×	359 0.7×	278 0.7×	166 0.6×	120	1.6k
Marina Korotkova Sweden	30	316 0.4×	324 0.5×	535 1.1×	709 1.7×	259 0.9×	77	2.5k
G Michaëlsson Sweden	35	355 0.5×	946 1.5×	286 0.6×	554 1.4×	661 2.2×	95	3.2k
Anthony P. Sampson United Kingdom	32	2.0k 2.8×	529 0.8×	537 1.1×	397 1.0×	160 0.5×	81	3.0k
Nicholas A. Pawlowski United States	23	566 0.8×	317 0.5×	236 0.5×	322 0.8×	48 0.2×	38	1.8k

Countries citing papers authored by Michael Shipley

Since Specialization

Citations

This map shows the geographic impact of Michael Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shipley more than expected).

Fields of papers citing papers by Michael Shipley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shipley. The network helps show where Michael Shipley may publish in the future.

Co-authorship network of co-authors of Michael Shipley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Shipley. A scholar is included among the top collaborators of Michael Shipley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Shipley. Michael Shipley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shipley, Michael. (2011). Hyperuricaemia and gout. The Journal of the Royal College of Physicians of Edinburgh. 41(3). 229–233. 11 indexed citations

Rahman, Anisur, et al.. (2008). Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic. Lara D. Veeken. 47(12). 1803–1808. 39 indexed citations

Breivik, Harald & Michael Shipley. (2007). Pain : best practice & research compendium. Elsevier eBooks. 3 indexed citations

Birns, Jonathan, Yiannis Ioannou, & Michael Shipley. (2005). An unusual case of weight loss in a patient with refractory rheumatoid arthritis. Age and Ageing. 34(3). 305–306.

Silman, Alan J. & Michael Shipley. (1997). Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data. Lara D. Veeken. 36(5). 599–601. 38 indexed citations

Crockard, H. Alan, Ronald Moskovich, H. Louis Harkey, et al.. (1994). Nystagmus and Joint Position Sensation. Spine. 19(1). 16–20. 8 indexed citations

Corbett, M, Seamus E. Dalton, Amanda Young, Alan J. Silman, & Michael Shipley. (1993). FACTORS PREDICTING DEATH, SURVIVAL AND FUNCTIONAL OUTCOME IN A PROSPECTIVE STUDY OF EARLY RHEUMATOID DISEASE OVER FIFTEEN YEARS. Lara D. Veeken. 32(8). 717–723. 103 indexed citations

Higgins, Colleen M., et al.. (1992). Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.. Annals of the Rheumatic Diseases. 51(7). 855–862. 3 indexed citations

Bamji, Andrew, et al.. (1990). WHAT DO RHEUMATOLOGISTS DO? A PILOT AUDIT STUDY. Lara D. Veeken. 29(4). 295–298. 18 indexed citations

10.

Jones, M. G. K., et al.. (1990). Specificity of rheumatoid factors in relation to the disease state in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 49(10). 757–762. 10 indexed citations

11.

Young, Amanda, et al.. (1988). IgA and IgM Rheumatoid Factors as Markers of Later Erosive Changes in Rheumatoid Arthritis (RA). Scandinavian Journal of Rheumatology. 17(sup75). 238–243. 26 indexed citations

12.

Shipley, Michael, P A Bacon, H Berry, et al.. (1988). PULSED METHYLPREDNISOLONE IN ACTIVE EARLY RHEUMATOID DISEASE: A DOSE-RANGING STUDY. Lara D. Veeken. 27(3). 211–214. 18 indexed citations

13.

Awad, J., H. Festenstein, A.H.L. Fielder, et al.. (1986). HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis.. Disease Markers. 4(1-2). 99–102. 2 indexed citations

14.

Kirk, Alison, J. Awad, H. Festenstein, et al.. (1986). HLA ANTIGENS IN PALINDROMIC RHEUMATISM AND PALINDROMIC ONSET RHEUMATOID ARTHRITIS. Lara D. Veeken. 25(4). 345–348. 15 indexed citations

15.

Kurtz, A. B., et al.. (1986). ASSOCIATION BETWEEN CHEIROARTHROPATHY AND FROZEN SHOULDER IN PATIENTS WITH INSULIN-DEPENDENT DIABETES MELLITUS. Lara D. Veeken. 25(2). 141–146. 49 indexed citations

16.

Shipley, Michael, et al.. (1983). CONTROLLED TRIAL OF HOMOEOPATHIC TREATMENT OF OSTEOARTHRITIS. The Lancet. 321(8316). 97–98. 65 indexed citations

17.

Ford‐Hutchinson, A W, M.A. Bray, Michael Shipley, Mira Doig, & M. J. H. Smith. (1980). Leukotriene B: A potent mediator of leucocyte function released from polymorphonuclear leucocytes. International Journal of Immunopharmacology. 2(3). 232–232. 13 indexed citations

18.

Cunningham, Fiona, Michael Shipley, & M. J. H. Smith. (1980). Aggregation of rat polymorphonuclear leucocytes in vitro. Journal of Pharmacy and Pharmacology. 32(1). 377–380. 45 indexed citations

19.

Shipley, Michael, et al.. (1980). A DOUBLE-BLIND CROSS-OVER TRIAL OF INDOMETHACIN, FENOPROFEN AND PLACEBO IN ANKYLOSING SPONDYLITIS, WITH COMMENTS ON PATIENT ASSESSMENT. Lara D. Veeken. 19(2). 122–125. 7 indexed citations

20.

Curzon, G., et al.. (1973). SUSTAINED-RELEASE LEVODOPA IN PARKINSONISM. The Lancet. 301(7806). 781–781. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact